Muhammed DEMİR, Mehmet ÖZBEK, Adem AKTAN, Tuncay GÜZEL, Burhan ASLAN, Hakkı ŞİMŞEK

Prognostic Significance of Monocyte to High-density Lipoprotein Ratio in Patients With Chronic Coronary Artery Occlusion

Objective: Monocyte to high-density lipoprotein ratio (MHR) is a biomarker of inflammatory response. In this study, we investigated the relationship between MHR and mortality in patients with chronic coronary artery occlusion (CTO). Method: Retrospective observational study including 493 patients over a follow up period of 73 months. Blood samples were taken before cardiac catheterization for coronary angiography. Results: Median follow-up was 48 months(26-73) . Patients were seperated into two groups: (I) MHR

Keywords:

Prognosis, inflammation mortality, atherosclerosis, Prognosis, inflammation, mortality, atherosclerosis,

PDF

___

1. Fefer P, Knudtson ML, Cheema AN, et all. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012; 59: 991–7.
2. Jeroudi OM, Alomar ME, Michael TT, et all. Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital. Catheter Cardiovasc Interv 2014; 84:637– 43.
3. Stone GW, Kandzari DE, Mehran R, et all. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 2005; 112:2364–72.
4. Cohen HA, Williams DO, Holmes DR, et all. NHLBI Dynamic Registry. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Am Heart J. 2003; 146:513-9.
5. Godino C, Sharp AS, Carlino M, Colombo A. Crossing CTOs-the tips, tricks, and specialist kit that can mean the difference between success and failure. Catheter Cardiovasc Interv. 2009; 74: 1019– 46.
6. Ammirati E., Moroni F., Magnoni M., et all. Circulating CD14+ and CD14 high CD16 classical monocytes are reduced in patients with signs of plaque neovascularization in the carotid artery. Atherosclerosis, 2016; 255: 171–8.
7. Aukrust P., Halvorsen B., Yndestad A., et all. Chemokines and cardiovascular risk. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008; 28: 1909–19.
8. Tani S., Matsumoto M., Anazawa T., et all. Development of a model for prediction of coronary atherosclerotic regression: Evaluation of high density lipoprotein cho esterol level and peripheral blood monocyte count. Heart and Vessels,2012; 27: 143–50.
9. Acikgoz N., Kurtoğlu E., Yagmur J., et all. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in behçet disease. Angiology. 2017; 69: 65–70.
10. Ganjali S., Momtazi A. A., Banach M., et all. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions. Progress in Lipid Research. 2017; 67, 16–26.
11. Gomaraschi M., Basilico N., Sisto F., et aLl. High density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro inflammatory stimuli. Biochimica et Biophysica Acta. 2005; 1736: 136–43.
12. D. Muhammed, Ö. Mehmet, A. Adem, E. Faruk. Fibrinogen to Albumin Ratio Predicts Burden of Coronary Artery Disease in Patients with NSTEMI. Dicle Med J 2021; 48:688-95.
13. Cetin EH, Cetin MS, Canpolat U, et all. Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Biomark Med. 2015; 9:967-77.
14. Fan Z, Ji H, Li Y, et al. Relationship between monocyte-to-lymphocyte ratio and coronary plaque vulnerability in patients with stable angina. Biomark. Med. 2017; 11: 979–90.
15. Canpolat U, Aytemir K, Yorgun H, et all. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace. 2015; 17:1807-15.
16. Canpolat U, Çetin EH, Cetin S, et al. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation. Clin Appl Thromb Hemost. 2016; 22:476-82.
17. Demir V, Samet Y, Akboga MK. Association of lymphocyte-monocyte ratio and monocyte-to-high density lipoprotein ratio with the presence and severity of rheumatic mitral valve stenosis. Biomark. Med.2017; 11: 657–63.
18. Ekizler FA, Cay S, Açar B, et all. Monocyte to high density lipoprotein cholesterol ratio predicts adverse cardiac events in patients with hypertrophic cardiomyopathy. Biomark Med. 2019; 13:1175-86.
19. Surya I.K.R., Wita I.W., Iswari I.S., et all. High Ratio of Monosit: High-Density Lipoprotein as a Risk Factor Of chronic Total Occlusion in Patients Coronary Artery Disease. Asian Journal of Pharmaceutical and Clinical Research, 2020;13:155- 8.
20. Bolayir A, Gokce SF, Cigdem B, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018; 52:150-5.
21. Efe T, Arslan E, Ertem A, ve ark. Akut Pulmoner Emboli Hastalarında Monosit/HDL Oranının Kısa Dönem Mortaliteyi Ön Gördürmedeki Prognostik Değeri. Koşuyolu Heart Journal. 2016; 19: 149-53.
22. Wu TT., Zheng YY., Chen Y., et all. Monocyte to high-density lipoprotein cholesterol ratio as long term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids Health Dis 2019;18, 180.
23. Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ. The anti-inflammatory effects of high density lipoproteins. Curr Med Chem. 2009; 16:667-75.
24. Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010; 37:710-18.
25. Yvan-Charvet L, Pagler T, Gautier EL, et all. ATP binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010;328:1689-93.
26. Wrigley BJ, Shantsila E, Tapp LD, Lip GY. CD14++CD16+ monocytes in patients with acute ischaemic heart failure. Eur J Clin Invest. 2013 Feb; 43:121-30.
27. Li, Chenguang, et al. "Impact of neutrophil to lymphocyte ratio (NLR) index and its periprocedural change (NLRΔ) for percutaneous coronary intervention in patients with chronic total occlusion." Angiology 68.7 (2017): 640-6.